Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma

Cancer Research

Volumn 57, Issue 15, 1997, Pages 3272-3280

  Gilbertson, Richard J ^a   Perry, Robert H ^b   Kelly, Peter J ^a   Pearson, Andrew D J ^c   Lunec, John ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR;

ADOLESCENT; ARTICLE; CELL TRANSFORMATION; CHILD; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE;

ADOLESCENT; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; MEDULLOBLASTOMA; MULTIVARIATE ANALYSIS; NEUREGULINS; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; SURVIVAL RATE; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION FACTORS;

EID: 0030741967     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. R tumour antigen. Nature (Lond.), 312: 513-516, 1984.
2. Kraus, M. H., Issing, W., Toru, M., Popescu, N. C., and Aaronson, S. A. Isolation and characterisation of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc. Natl. Acad. Sci. USA, 86: 9193-9197, 1989.
3. Plowman, G. D., Whitney, G. S., Neubauer, M. G., Green, J. M., McDonald, V. L., Todaro, G. J., and Shoyab, M. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proc. Natl. Acad. Sci. USA, 87: 4905-4909, 1990.
4. erbB4, a fourth member of the epidermal growth factor receptor family. Proc. Natl. Acad. Sci. USA, 90: 1746-1750, 1993.
5. HER2 causes transformation and tumorigenesis of NIH/ 3T3 cells. Proc. Natl. Acad. Sci. USA, 84: 7159-7163, 1987.
6. DiFiore, P. P., Pierce, J., Kraus, M. H., Segatto, O., King, C. R., and Aaronson, S. A. c-erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science (Washington DC), 237: 178-182, 1987.
7. DiFiore, P. P., Pierce, J. H., Fleming, T. P., Hazan, R., Ullrich, A., King, C. R., Schlessinger, J., and Aaronson, S. A. Overexpression of the human EGF receptor confers an EGF dependent transformed phenotype to NIH 3T3 cells. Cell, 51: 1063-1070, 1987.
8. Marco, E. D., Pierce, J. H., Fleming, T. P., Kraus, M. H., Molloy, C. J., Aaronson, S. A., and DiFiore, P. P. Autocrine interaction between TGF α and the EGF receptor: quantitative requirements for induction of the malignant phenotype. Oncogene, 4: 831-838, 1989.
9. Filmus, J., Trent, J. M., Pollack, M. N., and Buick, R. N. Epidermal growth factor receptor gene-amplified MDA-A468 breast cancer cell line and its nonamplified variants. Mol. Cell. Biol., 7: 251-257, 1987.
10. Gullick, W. J., Berger, M. S., Bennett, P. L. P., Rothbard, J. B., and Waterfield, M. D. Expression of the c-erbB-2 protein in normal and transformed cells. Int. J. Cancer, 40: 246-254, 1987.
11. Carlin, C. R., Simon, D., Mattison, J., and Knowles, B. B. Expression and biosynthetic variation of the epidermal growth factor receptor in human hepatocellular carcinoma derived cell lines. Mol. Cell. Biol., 8: 25-34, 1988.
12. Kraus, M. H., Fedi, P., Starks, V., Muraro, R., and Aaronson, S. A. Demonstration of ligand-dependent signalling by the erbB3 tyrosine kinase and its constitutive activation in human breast cancer. Proc. Natl. Acad. Sci. USA, 90: 2900-2904, 1993.
13. Santon, J. B., Cronin, M. T., MacLeod, C. L., Mendelson, J., Masui, H., and Gill, G. N. Effects of epidermal growth factor receptor concentration on tumorigenicity of A431 cells in nude mice. Cancer Res., 46: 4701-4705, 1986.
14. Aboud-Pirak, E., Hurwitz, E., Pirak, M. E., Bellot, F., Schlessinger, J., and Sela, M. Efficacy of antibodies to epidermal growth factor receptor against Kb carcinoma cells in vitro and in nude mice. J. Natl. Cancer Inst., 80: 1605-1611, 1988.
15. Muller, B. M., Romerdahl, C. A., Trent, J. M., and Reisfeld, R. A. Suppression of spontaneous melanoma metastasis in scid mice with an antibody to the epidermal growth factor receptor. Cancer Res., 51: 2193-2198, 1991.
16. Stankovski, I., Hurwitz, E., Leitner, O., Ullrich, A., Yarden, Y., and Sela, M. Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth. Proc. Natl. Acad. Sci. USA, 88: 8691-8695, 1991.
17. Dougall, W. C., Qian, X., Peterson, N. C., Miller, M. J., Samanta, A., and Greene, M. I. The neu oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene, 9: 2109-2123, 1994.
18. Poller, D. N., Spendlove, I., Baker, C., Church, R., Ellis, I. O., Plowman, G. D., and Mayer, R. J. Production and characterisation of a polyclonal antibody to the c-erbB3 protein: examination of c-erbB-3 protein expression in adenocarcinomas. J. Pathol., 168: 275-280, 1992.
19. Singleton, T. P., and Strickler, J. G. Clinical and pathological significance of the c-erbB-2 (HER2/neu) oncogene. Pathol. Annu., 27: 165-190, 1992.